What's happening
This bill requires schools to provide teachers with written information, approved by the health commissioner, on using epinephrine auto-injectors.
Why it matters
Increases teacher preparedness. By requiring schools to provide official, health commissioner-approved information on epinephrine auto-injector use, teachers are more likely to understand how to respond effectively during severe allergic reactions, potentially saving lives.
Standardizes training materials. Ensuring the information comes from a centralized, expert source (the health commissioner) reduces inconsistencies and misinformation, leading to clearer, more reliable guidance for all teachers across different types of schools.
Expands responsibility beyond public schools. The requirement covers not just public districts but also boards of cooperative educational services, charter schools, and non-public schools, meaning more students statewide are protected by having better-informed adults present.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
School districts, BOCES and county vocational education and extension boards
Those authorized to maintain epinephrine auto-injectors on-site would have to provide all teachers with written information on their use.
Charter schools and non-public elementary and secondary schools
Those authorized to maintain epinephrine auto-injectors on-site would face the same requirement to distribute written materials to all teachers.
Teachers
All teachers at covered schools would receive written information on using an epinephrine auto-injector, rather than being required by this bill to undergo training.
State health commissioner
The required informational materials would have to be created and approved by the commissioner.
Headline styles
Inform Teachers About EpiPens
Plain English, a few words. Used as the page title.
Sponsors
1 Co-sponsor
History
- Substituted by S209A
- Ordered to third reading rules cal.397
- Rules report cal.397
- Reported
- Reported referred to rules
- Print number 7037a
- Amend (t) and recommit to education
- Referred to education
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Give Teachers EpiPen Info
Signed by Governor · Sponsor Cordell Cleare
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
7037--A
2023-2024 Regular Sessions
IN ASSEMBLY
May 10, 2023
Introduced by M. of A. L. ROSENTHAL -- read once and referred to the Committee on Education -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee
AN ACT to amend the education law, in relation to requiring schools to provide teachers with written informational material on the use of epinephrine auto-injectors
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Section 921-a of the education law is amended by adding a new subdivision 3 to read as follows:
3. School districts, boards of cooperative educational services, county vocational education and extension boards, charter schools, and non-public elementary and secondary schools in this state that are authorized to provide and maintain epinephrine auto-injectors on-site pursuant to this section shall provide all teachers with written informational material on the use of an epinephrine auto-injector that has been created and approved by the commissioner of health.
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD00744-06-3
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.